Advances in Allergy, Asthma and Immunology
过敏、哮喘和免疫学的进展
基本信息
- 批准号:6531773
- 负责人:
- 金额:$ 1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-07-01 至 2005-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Allergy is one of the most common reasons that individuals use alternative and complementary medicine (CAM). There is a plethora of reports regarding CAM in the treatment of allergy, asthma and immunology, but there is a dirth of scientific studies, plenary sessions, workshops presented in the nationally recognized forums. Objective: This application plans to explore "state of the art" CAM practices and "integrate" them into the annual meetings of the 2 major Allergy and Immunology organizations (American College of Allergy, Asthma and Immunology (ACAAI) and the American Academy of Allergy, Asthma and immunology (AAAAI) by: 1) providing the initial infrastructure for the submission of rigorous original scientific information related to allergic, asthmatic and immunologic disorders; 2) developing an ongoing scientific forum within the framework of the national organizations; 3) generating new research ideas and facilitating collaboration; and 4) publishing the proceedings and providing an ongoing internet resource site related to this application. This will be coordinated by the CAM Oversight Committee (CAMOC) consisting of respected allergy and immunology researchers in conjunction with the UMDNJ - Asthma & Allergy Research Center and the Center for the Study of Alternative and Complementary Medicine. The CAM Advisory Board (CAMAB) will be constituted with leaders from professional national organizations to provide multidisciplinary panel discussions and to generate CAM research priorities for these disciplines as they relate to allergy, asthma and immunology. Preliminary Work: Single workshops have been instituted at each of the upcoming annual meetings (ACAAI 11/01 and AAAAI 03/02). Commitments for a whole day CAM symposium at the ACAAI (11/14/02) and the publication of the proceedings have been obtained. The tentative schedule provides for the Overview of CAM; Overview of Herbal Medicine in Asthma; Overview of Homeopathy in Allergies; Overview of Probiotics in Atopic Dermatitis; Medico-Legal Aspects and Adverse Reactions. Summary: This application will provide the catalyst for establishing an ongoing forum for the review and promotion of scientifically based research assessing the impact of CAM in allergy, asthma and immunology.
描述(由申请人提供):过敏是个人使用替代和补充医学 (CAM) 的最常见原因之一。关于 CAM 在过敏、哮喘和免疫学治疗中的报道有很多,但在国家认可的论坛上却有大量的科学研究、全体会议、研讨会。目标:该应用程序计划探索“最先进”的 CAM 实践,并将其“整合”到 2 个主要过敏和免疫学组织(美国过敏、哮喘和免疫学学会 (ACAAI) 和美国过敏、哮喘和免疫学学会 (AAAAI))的年会上:1) 为提交与过敏、哮喘相关的严格原始科学信息提供初始基础设施 和免疫系统疾病; 2)在国家组织的框架内建立一个持续的科学论坛; 3)产生新的研究思路并促进合作; 4) 公布会议记录并提供与本申请相关的持续互联网资源站点。这将由 CAM 监督委员会 (CAMOC) 进行协调,该委员会由受人尊敬的过敏和免疫学研究人员组成,与 UMDNJ - 哮喘和过敏研究中心以及替代和补充医学研究中心合作。 CAM 咨询委员会 (CAMAB) 将由来自专业国家组织的领导人组成,提供多学科小组讨论,并为这些与过敏、哮喘和免疫学相关的学科制定 CAM 研究重点。初步工作:在即将举行的每次年会(ACAAI 11/01 和 AAAAI 03/02)上都举办了单独的研讨会。已获得在 ACAAI(2002 年 11 月 14 日)举行全天 CAM 研讨会并出版会议记录的承诺。暂定时间表提供了 CAM 概述;哮喘草药概述;过敏症顺势疗法概述;益生菌在特应性皮炎中的概述;医疗法律方面和不良反应。摘要:该应用程序将为建立一个持续论坛提供催化剂,以审查和推广基于科学的研究,评估 CAM 在过敏、哮喘和免疫学方面的影响。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The science of complementary and alternative medicine: the plural of anecdote is not evidence.
补充和替代医学的科学:轶事的复数不是证据。
- DOI:10.1016/s1081-1206(10)61480-9
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Bielory,Leonard
- 通讯作者:Bielory,Leonard
Clinical efficacy, mechanisms of action, and adverse effects of complementary and alternative medicine therapies for asthma.
哮喘补充和替代医学疗法的临床疗效、作用机制和不良反应。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:2.8
- 作者:Bielory,Leonard;Russin,Jonathan;Zuckerman,GaryB
- 通讯作者:Zuckerman,GaryB
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LEONARD BIELORY其他文献
LEONARD BIELORY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LEONARD BIELORY', 18)}}的其他基金
相似海外基金
Defining new asthma phenotypes using high-dimensional data
使用高维数据定义新的哮喘表型
- 批准号:
2901112 - 财政年份:2024
- 资助金额:
$ 1万 - 项目类别:
Studentship
Basophilic oncostatin M fuels nociceptor neuron-induced asthma
嗜碱性制瘤素 M 促进伤害感受器神经元诱发哮喘
- 批准号:
485504 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Salary Programs
Engaging Patient and Caregivers in Using Patient-reported Outcomes Measures in Pediatric Clinical Care for Asthma
让患者和护理人员参与儿科哮喘儿科临床护理中患者报告的结果测量
- 批准号:
495593 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Air pollution and Asthma in Canada: Projections of burden and the value of climate adaptation strategies
加拿大的空气污染和哮喘:负担预测和气候适应战略的价值
- 批准号:
485322 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
- 批准号:
493135 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
- 批准号:
493526 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Operating Grants
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
- 批准号:
10659658 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Treating Maternal Depression in an Urban Community-Based Pediatric Asthma Clinic: Targeting Maternal Mood, Child Asthma Outcomes, and Health Disparities
在城市社区小儿哮喘诊所治疗孕产妇抑郁症:针对孕产妇情绪、儿童哮喘结果和健康差异
- 批准号:
10723233 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Improving Prediction of Asthma-related Outcomes with Genetic Ancestry-informed Lung Function Equations
利用遗传祖先信息的肺功能方程改善哮喘相关结果的预测
- 批准号:
10723861 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Prenatal Fatty Acid Supplementation and Early Childhood Asthma and Atopy in Black American Families
美国黑人家庭产前脂肪酸补充剂与儿童早期哮喘和特应性
- 批准号:
10586398 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:














{{item.name}}会员




